The National Science Foundation (NSF) awarded a $650,000 Project Grant under its Engineering program (CFDA 47.041) to Rowan University in Glassboro, NJ, effective July 1, 2025 through June 30, 2030. The goal of this project is to develop lipid nanoparticles (LNPs) as tools to study how oxygen levels and inflammation influence pregnancy health. The research aims to uncover potential therapeutic strategies to treat diseases of pregnancy and other diseases characterized by low oxygen or excessive inflammation. The project integrates both non-living and living components to form a fundamental understanding of the molecular drivers of pathophysiology during pregnancy. Successful completion of this work is expected to establish LNPs as tools for studying pathophysiology across numerous diseases driven by hypoxia or inflammation, leading to the development of new therapeutic approaches. No sub-awards are planned for this award.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| Not listed | $650.0k | 6/4/25 |